文献速递临床生化质量管理与危急值

基于声流控的采血与血浆分离技术:减少采样相关失血的初步研究

Acoustophoresis-based blood sampling and plasma separation for potentially minimizing sampling-related blood loss.
PubMed 文献 · Clin Chem Lab Med · 2025-07-07

本研究评估了一种基于声流控(acoustophoresis)的在线采血与血浆分离装置原型,旨在为早产儿等脆弱患者减少采血相关失血。研究从健康成人供者采集全血,将声流控分离血浆与离心血浆(2000g×10min)进行比较,检测细胞计数、游离血红蛋白及12项常规临床化学分析物。结果显示声流控血浆残留细胞和血小板更多,但游离血红蛋白更低,部分分析物存在统计学显著差异,提示该技术有潜力产生适用于部分常规临床化学分析的无细胞血浆。

要点

  • 声流控与离心均可使残留细胞低于0.01%,但声流控血浆中细胞和血小板残留更多。
  • 声流控血浆游离血红蛋白范围0.0-0.2 g/L,低于离心血浆的0.1-0.3 g/L。
  • 12项常规临床化学分析物中,钠相对平均差异0.84%(95%CI 0.48-1.19),AST为10.50%(95%CI 5.02-15.99)。

核心结论

  • 声流控技术有潜力产生足够无细胞的血浆用于若干常规临床化学分析。
  • 需进一步研究病理样本、血小板活化并改进设计以更有效去除血小板。

研究设计与样本

  • 研究从健康成人供者采集全血于无凝胶锂肝素管,比较声流控分离血浆与离心血浆(2000g×10min)。
  • 细胞计数比较n=14,游离血红蛋白比较n=21,12项常规临床化学分析物比较n=21。
  • 采用Wilcoxon符号秩检验和Bland-Altman分析进行统计比较。

主要发现

  • 声流控和离心分离后残留细胞均低于0.01%。
  • 声流控血浆中残留细胞中位数642/μL vs 离心205/μL(p<0.01),血小板中位数20477/μL vs 1537/μL(p<0.0001)。
  • 声流控血浆游离血红蛋白范围0.0-0.2 g/L,低于离心血浆的0.1-0.3 g/L(p<0.01)。
  • 12项分析物相对平均差异从钠的0.84%(95%CI 0.48-1.19)到AST的10.50%(95%CI 5.02-15.99)不等,差异有统计学意义。

关键数值与推荐

  • 离心条件:2000g×10min。
  • 残留细胞阈值:声流控和离心均<0.01%。
  • 声流控血浆残留细胞中位数642/μL,血小板20477/μL;离心血浆分别为205/μL和1537/μL。
  • 声流控血浆游离血红蛋白0.0-0.2 g/L;离心血浆0.1-0.3 g/L。
  • 分析物相对平均差异范围0.84%(钠,95%CI 0.48-1.19)至10.50%(AST,95%CI 5.02-15.99)。

临床怎么用

  • 该原型装置可能用于脆弱患者群体的在线采血,减少采样相关失血和输血需求。
  • 对于钠等差异较小的分析物,声流控血浆与离心血浆结果接近;对于AST等差异较大的分析物需谨慎解读。
  • 目前仅为概念验证,尚未推荐用于临床常规检测。

局限性

  • 研究仅使用健康成人供者样本,未评估病理样本。
  • 未评估血小板活化情况。
  • 声流控血浆中血小板残留显著多于离心血浆,需改进设计以提高血小板去除效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Frequent blood sampling in vulnerable patient groups, such as prematurely born infants, can lead to significant blood loss and increased transfusion needs. Current pre-analytical technology requires comparably large blood volumes and leads to discarding of cells. This study investigates a device prototype enabling in-line sampling where cell-reduced plasma for clinical chemistry analyses is generated through acoustophoresis. METHODS: Blood samples were collected from healthy adult donors in lithium-heparin tubes without gel. Plasma separated via acoustophoresis was compared with centrifuged plasma (2000 g × 10 min) for cell counts (n=14), cell-free hemoglobin (n=21), and 12 routine clinical chemistry analyte tests (n=21). Wilcoxon signed-rank tests and Bland Altman analysis were used for statistical comparison. RESULTS: Both acoustophoresis (AF) and centrifugation (CEN) generated cell-reduced plasma with<0.01 % of cells remaining after separation. However, compared to CEN plasma, more cells (median count per μL 642 vs. 205, p<0.01) and platelets (median count per μL 20,477 vs. 1,537, p<0.0001) remained in AF plasma. Cell-free hemoglobin (fHb) in AF plasma samples (range 0.0-0.2 g/L) was lower (p<0.01) than in CEN plasma samples (range 0.1-0.3 g/L). Statistically significant relative mean differences in test results ranging from 0.84 % (95 % CI 0.48-1.19) for sodium to 10.50 % (95 % CI 5.02-15.99) for AST were found. CONCLUSIONS: This proof-of-concept study demonstrates that acoustophoresis has the potential to produce sufficiently cell-free plasma for several commonly performed clinical chemistry analyses. Further studies should assess pathological samples, platelet activation, and improve the design for more efficient removal of platelets.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Nath A, Larsson SM, Lenshof A, et al. Acoustophoresis-based blood sampling and plasma separation for potentially minimizing sampling-related blood loss. Clin Chem Lab Med. 2025. PMID: 40613108. doi:10.1515/cclm-2025-0539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。